Welcome to 3i

For US regulatory reasons, US Residents are not to enter this site without the express permission of 3i Group plc, and 3i Group plc is not offering any securities or services in the United States or to US Residents through this site. (The term "US Residents" is defined in the detailed terms and conditions set out in the Terms and conditions page).

I am not a US resident (or I am, but I have 3i Group plc's express permission to use this site) and I accept the terms and conditions.

Terms and conditions

US Richard Relyea 2994

Richard Relyea

Partner, Managing Director

  • Business line Private Equity
  • Location North America
  • Year Joined 2007

Richard joined 3i in 2007 and is Head of 3i’s North American Private Equity team and the Global Head of Healthcare.

He has been involved in 3i’s investments in Mold-Masters, Quintiles, Q Holding, Dynatect Manufacturing, Cirtec Medical, SaniSure and ten23 Health. He currently sits on the Boards of Q Holding, Dynatect Manufacturing, Cirtec Medical, SaniSure and ten23 Health, and previously sat on the Boards of Quintiles and Mold-Masters.

Prior to joining 3i, Richard was a Principal at Halyard Capital, where he invested in companies in the media, business services and communications sectors. Prior to joining Halyard, Richard was an Associate at Entrade, where he invested in technology and internet infrastructure businesses.

Richard began his career at Security Capital's Preferred Growth Private Equity fund.